Sarissa Capital Management as of March 31, 2017
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 11 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medicines Company | 33.9 | $86M | 1.8M | 48.90 | |
| Biogen Idec (BIIB) | 33.5 | $85M | 310k | 273.42 | |
| Innoviva (INVA) | 18.7 | $47M | 3.4M | 13.83 | |
| Noveliontherapeuti.. | 4.3 | $11M | 1.0M | 10.74 | |
| Bioverativ Inc Com equity | 3.3 | $8.4M | 155k | 54.46 | |
| Intra Cellular Therapies (ITCI) | 2.3 | $5.9M | 360k | 16.25 | |
| Apricus Biosciences | 1.2 | $3.1M | 1.4M | 2.11 | |
| Vivus | 1.1 | $2.9M | 2.6M | 1.12 | |
| Advaxis | 1.1 | $2.8M | 339k | 8.17 | |
| Abbvie (ABBV) | 0.3 | $651k | 10k | 65.10 | |
| AVEO Pharmaceuticals | 0.2 | $598k | 1.0M | 0.59 |
